New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modeling in Canadian Medical Association Journal.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup